Key Enzyme Linked to Therapy Resistance in Deadly Lung Cancer

09:45 EST 11 Dec 2018 | Laboratory Equipment

News
Researchers have identified a link between an enzyme tied to cancer formation and therapy resistance in patients with epidermal growth factor receptor-mutant non-small cell lung cancer.
Contributed Author: 
University of Texas M. D. Anderson Cancer Center
Topics: 
Animal Lab News

Original Article: Key Enzyme Linked to Therapy Resistance in Deadly Lung Cancer

More From BioPortfolio on "Key Enzyme Linked to Therapy Resistance in Deadly Lung Cancer"